Company Planning to Make COVID-19 Vaccine in Canada Could Go out of Business

Scientists examine a step in the vaccine purification process as they design updates to the Novavax's COVID-19 shots in the company's research laboratory in Gaithersburg, Md on May 24, 2022. The Associated Press/Angie Wang

An American company that signed a deal with the federal government to produce COVID-19 vaccines in Montreal has warned investors it could go out of business within the year.

Executives at Maryland-based Novavax told investors on a conference call Tuesday that there is significant uncertainty surrounding the company’s ability to continue funding operations as the market for COVID-19 vaccines changes.